Email Updates

Search form

You are here

Webinar & Meeting Reports

  • November 24, 2014

    This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention on 23-25th January 2015 in Brussels. The second webinar covered pre-exposure prophylaxis (PrEP). The third webinar covered vaccines and microbicides on the 12th December.

  • November 19, 2014

    Women play a key role in the success of VMMC programs. The webinar discussed the impact of VMMC on women, women's perceptions of VMMC, and their roles as partners, mothers and community members in the success of the VMMC program

  • November 17, 2014

  • November 12, 2014
    Multipurpose Prevention Technologies (MPTs) are a fast-growing area in women’s sexual and reproductive health. On November 12, AVAC and CAMI Health co-hosted a webinar: MPT Acceptability in Uganda, Nigeria and South Africa.
  • November 10, 2014

    This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention on 23-25th January 2015 in Brussels. 

    The first webinar addressed the latest updates on treatment as prevention. Speakers included Dr. Reuben Granich, Senior Advisor for Care and Treatment at UNAIDS, Dr. Sarah Fidler of Imperial College London, and Silvia Petretti, Deputy CEO of Positively UK.

  • November 6, 2014

    Following HIV R4P, AVAC held a webinar focused on the “state of the prevention union” according to civil society partners who attended the meeting and/or are working on relevant issues in their countries and communities.

  • November 4, 2014

    The status of HIV vaccines and how new technologies impact ongoing efforts were discussed by Anthony Faucci, Mitchell Warren, and Margie McGlynn at the Center for Strategic and International Studies

  • October 27, 2014 to October 31, 2014

    The HIV R4P conference is the first global conference to cover all forms of biomedical HIV prevention, including AIDS vaccines, microbicides, PrEP, treatment as prevention and other approaches. It replaces the microbicide- and vaccine-specific conferences that have taken place in the past, and has been designed to provide a unified forum for addressing both intervention-specific and cross-cutting issues.

  • October 14, 2014
    A New-York based panel discussion featured doctors, PrEP users, activists, focusing on what PrEP means for women.
  • October 8, 2014

    In Melbourne, UNAIDS launched a new initiative known as “90-90-90”, which lays out new targets for testing, treatment and virologic suppression. Where did these targets come from, what do they mean—and where does prevention fit in? Chris Collins, Chief of the Community Mobilization Division at UNAIDS addressed these questions and more.

Pages